Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Belarusian parliament passes a bill to crack down on LGBTQ+ rights - 2Involved Vehicles for Seniors: Track down the Best Picks for Solace and Unwavering quality
- 3This star-forming galaxy is blowing out powerful winds topping 2 million mph
- 4Qatar, Ireland accuse Israel of using chemical weapons on Palestinians, demand watchdog probe use
- 5Flu illness count nears 5 million, with New York City among the hardest hit
- China's 'Venice Of The East' Is A Historic Canal City Near Shanghai With Arched Bridges And Lantern-Lit Waterways
- French high-speed train slams into truck, killing TGV driver
- First Alert: Light snow through this evening
- The most effective method to Shake Hands Expertly: A Bit by bit Guide
- UK clothing inflation climbs as Middle East turmoil threatens wider price rises
- Comet Lemmon and Milky Way spotted over Hawaii | Space photo of the day for Dec. 12, 2025
- Vote In favor of Your #1 Electric Vehicles
- 5 Great and High Evaluated Scene Configuration Administrations For 2024
- Ukrainian Army Converts E38 BMW 7-Series Into Multiple Rocket Launch Platform
